Advertisement

U.S. markets closed

S&P Futures
4,271.25
-9.75(-0.23%)
Dow Futures
33,646.00
-72.00(-0.21%)
Nasdaq Futures
13,547.25
-30.50(-0.22%)
Russell 2000 Futures
2,012.00
-4.90(-0.24%)
Crude Oil
91.66
-0.43(-0.47%)
Gold
1,815.70
+0.20(+0.01%)

Advertisement

Allied Healthcare Products, Inc. (AHPI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

2.1000

-0.0300

(-1.41%)

At close: 04:00PM EDT

2.0900

-0.01

(-0.48%)

After hours:

07:56PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	2.1300
Open	2.1000
Bid	2.0800 x 1200
Ask	2.1900 x 800
Day's Range	2.0605 - 2.1500
52 Week Range	1.5500 - 12.1500
Volume	28,352
Avg. Volume	194,058

Market Cap	8.428M
Beta (5Y Monthly)	-3.17
PE Ratio (TTM)	N/A
EPS (TTM)	-0.4670
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Jun 26, 1996
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AHPI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Allied Healthcare Products, Inc
Analyst Report: ResMed Inc.ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Rating
Fair Value
Economic Moat
3 days agoMorningstar